ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

NCAB Discussion Of Working Group Report

February 28, 2003

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

In Brief: Lane Adams Retires, Gadberry New Executive VP; Lemaistre ACS President, Loeb President Elect

November 15, 1985

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

Not All Women Benefitting From Less Invasive Staging

April 25, 2008